Cargando…

The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance

Developing a user-friendly platform that can handle a vast number of complex physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models both for conventional small molecules and larger biologic drugs is a substantial challenge. Over the last decade the Simcyp Population Based Simulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamei, Masoud, Marciniak, Steve, Edwards, Duncan, Wragg, Kris, Feng, Kairui, Barnett, Adrian, Rostami-Hodjegan, Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230310/ https://www.ncbi.nlm.nih.gov/pubmed/25505654 http://dx.doi.org/10.1186/2193-9616-1-9

Ejemplares similares

A Tutorial on Pharmacodynamic Scripting Facility in Simcyp
por: Abduljalil, K, et al.
Publicado: (2016)

Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers
por: Wedagedera, Janak R., et al.
Publicado: (2022)

Guide to development of compound files for PBPK modeling in the Simcyp population‐based simulator
por: Ezuruike, Udoamaka, et al.
Publicado: (2022)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz
por: Chetty, Manoranjenni, et al.
Publicado: (2018)

SimRFlow: An R-based workflow for automated high-throughput PBPK simulation with the Simcyp(®) simulator
por: Khalidi, Hiba, et al.
Publicado: (2022)

Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
por: Frechen, Sebastian, et al.
Publicado: (2022)

In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform
por: Spanakis, Marios, et al.
Publicado: (2014)

Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
por: Liu, Dan, et al.
Publicado: (2020)

Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site
por: Musther, Helen, et al.
Publicado: (2015)

Prediction of CYP‐mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator
por: Kilford, Peter J., et al.
Publicado: (2022)

Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model
por: Chetty, Manoranjenni, et al.
Publicado: (2015)

Does age affect gastric emptying time? A model‐based meta‐analysis of data from premature neonates through to adults
por: Bonner, Jennifer J., et al.
Publicado: (2015)

Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21
por: Sychterz, Caroline, et al.
Publicado: (2022)

Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information
por: Mishra, H, et al.
Publicado: (2014)

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability
por: Chetty, Manoranjenni, et al.
Publicado: (2014)

Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
por: Darwich, A S, et al.
Publicado: (2013)

Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence
por: Rostami‐Hodjegan, Amin
Publicado: (2017)

Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin
por: Rose, R H, et al.
Publicado: (2014)

Enterprise Architecture and Information Assurance
por: Scholz, James
Publicado: (2013)

Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model
por: Almond, Lisa M., et al.
Publicado: (2016)

A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine
por: Jamei, M., et al.
Publicado: (2013)

LHCb - Quality assurance of the LHCb Simulation
por: Popov, Dmitry
Publicado: (2022)

LHCb - Quality assurance of the LHCb Simulation
por: Popov, Dmitry
Publicado: (2022)

Opening a debate on open‐source modeling tools: Pouring fuel on fire versus extinguishing the flare of a healthy debate
por: Rostami‐Hodjegan, Amin, et al.
Publicado: (2021)

Quality assurance in psychiatry: quality indicators and guideline implementation
por: Wobrock, T., et al.
Publicado: (2009)

Transesophageal echocardiography in the emergency department: A comprehensive guide for acquisition, implementation, and quality assurance
por: McGuire, Duncan, et al.
Publicado: (2022)

Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters
por: Ahmad, Amais, et al.
Publicado: (2021)

PBPK modeling to predict drug‐drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction
por: Bolleddula, Jayaprakasam, et al.
Publicado: (2021)

The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
por: Cristea, Sînziana, et al.
Publicado: (2020)

Quality Assurance in Archaeological Survey
por: Banning, E. B., et al.
Publicado: (2016)

An overview of the quality assurance programme for HIV rapid testing in South Africa: Outcome of a 2-year phased implementation of quality assurance program
por: Woldesenbet, Selamawit Alemu, et al.
Publicado: (2019)

Precision medicine technology hype or reality? The example of computer-guided dosing
por: Polasek, Thomas M., et al.
Publicado: (2019)

Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs
por: Daali, Youssef, et al.
Publicado: (2022)

Quality assured implementation of the Slovenian breast cancer screening programme
por: Jarm, Katja, et al.
Publicado: (2021)

Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance
por: Scotcher, Daniel, et al.
Publicado: (2016)

Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling
por: Doki, Kosuke, et al.
Publicado: (2019)

Application of the Nested Enzyme‐Within‐Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects
por: Takita, Hiroyuki, et al.
Publicado: (2020)

Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling
por: Bego, Margareta, et al.
Publicado: (2022)

Enterprise architecture and information assurance : developing a secure foundation
por: Scholz, James A
Publicado: (2014)

Simplified “on‐couch” daily quality assurance procedure for CT simulators
por: Liu, Ruijie Rachel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i88ved9tqgeqc7g62fgjj3q6uc